Product Information

TOPIRAMATE 25 MG/ML SOLUTION is a generic product labeled by Ascend Laboratories, LLC, priced at $1.0826 per ML under NDC 67877083347. Its NADAC has been published 36 times since Dec 17, 2025.

FDA first approved this application on Oct 31, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 25 MG/ML SOLUTION

TOPIRAMATE
$1.0826per ML

Strength

25 mg/mL

NDC

67877083347

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217795

FDA Approved

10/31/2024

TE Code

AB

On Market Since

7/7/2025

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 25 MG/ML SOLUTION has been published 36 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.0826 per ML
All-time high$1.0929 (Jun 10, 2026)
All-time low$1.0667 (Feb 18, 2026)
52-week high$1.0929
52-week low$1.0667
Median price$1.0837
Average price$1.0799
Largest weekly change+1.3% (May 20, 2026)
Weeks tracked36
Tracking sinceDec 17, 2025

Price History

1W

-0.4%

1M

-0.4%

3M

-0.9%

6M

+1.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 25 MG/ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 25 MG/ML SOLUTION, manufactured by Ascend Laboratories, LLC, is $1.0826 per ML (NDC 67877083347), effective Aug 19, 2026.

How has the price of TOPIRAMATE 25 MG/ML SOLUTION changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 25 MG/ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 25 MG/ML SOLUTION?

Since Dec 17, 2025, the NADAC for TOPIRAMATE 25 MG/ML SOLUTION has ranged from a low of $1.0667 (Feb 18, 2026) to a high of $1.0929 (Jun 10, 2026), with a median of $1.0837 per ML.

Are there cheaper alternatives to TOPIRAMATE 25 MG/ML SOLUTION?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE 25 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE 25 MG/ML SOLUTION?

TOPIRAMATE 25 MG/ML SOLUTION (NDC 67877083347) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.